Read + Share
Shindo T. Editorial Comment to J-AVENUE: A retrospective, real-world study evaluating
patient characteristics and outcomes in patients with advanced urothelial
carcinoma treated with avelumab first-line maintenance therapy in Japan. Int J Urol 2024;31:867-868.
PMID: 38752600
|
 |
|
